SUPerficial ENDometriosis In Magnetic Resonance Imaging

NANot yet recruitingINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

April 30, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
Endometriosis
Interventions
RADIATION

Magnetic resonance imaging, 3DT1 sequence

The patient will have an exploration pelvic Magnetic Resonance Imaging lasting approximately 15 to 20 minutes, without systematic injection of contrast product.

PROCEDURE

Laparoscopy

After Magnetic Resonance Imaging, the patient will benefit from a laparoscopy under general anesthesia lasting an average of one hour.

Trial Locations (1)

75015

Clinique Blomet, Paris

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Euraxi Pharma

INDUSTRY

lead

GCS Ramsay Santé pour l'Enseignement et la Recherche

OTHER

NCT06195280 - SUPerficial ENDometriosis In Magnetic Resonance Imaging | Biotech Hunter | Biotech Hunter